Market: NYQ |
Currency:
Address:
📈 DD/I Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for DD/I
No earnings history available for this symbol.
📰 Related News & Research
-
Exicure, Inc. Reports 2025 Financial Results and Highlights Urgent Need for Additional Financing After GPCR USA Acquisition
March 26, 2026
Exicure, Inc. Releases Full Year 2025 Financial Results: Key...
-
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities
March 24, 2026
Serina Therapeutics Secures Up To \$30 Million to Advance Pa...
-
Strategy Inc (formerly MicroStrategy) Announces Omnibus Sales Agreement and Additional Program Addendum with Leading Financial Agents – March 2026 1422252830333536465060626466697176
March 23, 2026
Strategy Inc (formerly MicroStrategy) Announces Major Change...
-
Victory Capital Submits Superior $56.84 Per Share Cash and Stock Proposal to Acquire Janus Henderson, Outbidding Trian Deal
March 17, 2026
Victory Capital Submits Superior Proposal to Acquire Janus H...
-
Aldeyra Therapeutics Receives FDA Complete Response Letter for Reproxalap Dry Eye Disease Treatment, No Additional Trials Required 1
March 17, 2026
Aldeyra Therapeutics Receives FDA Complete Response Letter f...
-
Chasen Holdings Acquires Additional 22.05% Stake in Subsidiary RPT via Treasury Share Transfer
March 17, 2026
Chasen Holdings Limited: Detailed Analysis of Proposed Acqui...
-
Zhejiang Medicine Shareholder Plans to Reduce Stake by Up to 1% via Centralized Bidding – 2026 Announcement
March 16, 2026
主要内容概述 浙江医药股份有限公司(证券代码:600216)于2026年3月17日发布公告,披露持股5%以上大...
-
Zhejiang Pharmaceutical (600216) Major Shareholder Announces Up to 1% Share Reduction Plan via Centralized Bidding
March 16, 2026
浙江医药股份有限公司大股东减持公告深度解读 浙江医药股份有限公司大股东减持计划公告深度解读 一、公告要点概述 大股...
-
Inception Growth Acquisition Limited Extends Business Combination Deadline with Additional Trust Contribution
March 14, 2026
Inception Growth Acquisition Limited Extends Business Combin...
-
California Resources Corporation Announces $250 Million Private Offering of Additional 7.000% Senior Unsecured Notes Due 2034 to Redeem 2029 Notes
March 11, 2026
California Resources Corporation Announces \$250 Million Pri...
🔍 View more Reports